ArticleCancers2024

Intraperitoneal Chemotherapy without Bevacizumab versus Intravenous Chemotherapy with Bevacizumab as the Frontline Adjuvant Therapy in Advanced Ovarian Cancer.

Wan-Hua Ting et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.